Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study

Br J Dermatol. 2023 Dec 20;190(1):55-61. doi: 10.1093/bjd/ljad339.

Abstract

Background: Atopic dermatitis (AD) is the leading cause of the global burden from skin disease; no study has provided global and country-specific epidemiological estimates of AD.

Objectives: To quantify global, regional and country-specific estimates of the epidemiology of AD.

Methods: A comprehensive search for epidemiological studies in AD was conducted in four electronic databases (PubMed, Embase, Web of Science and China National Knowledge Infrastructure). A Bayesian hierarchical linear mixed model was constructed to calculate epidemiological estimates of AD considering the heterogeneity of regions, countries, type of diagnoses and age strata.

Results: In total, 344 studies met the inclusion criteria. Incidence varied substantially with the location and age of the surveyed participants. The global prevalence of AD and the population affected by AD were estimated to be 2.6% [95% uncertainty interval (UI) 1.9-3.5] and 204.05 million people, respectively. Around 101.27 million adults and 102.78 million children worldwide have AD, corresponding to prevalence rates of 2.0% (95% UI 1.4-2.6) and 4.0% (95% UI 2.8-5.3), respectively. Females were more likely to suffer from AD than males: the global prevalence of AD in females was 2.8% (95% UI 2.0-3.7%) and affected 108.29 million people, while in males the corresponding estimates were 2.4% (95% UI 1.7-3.3%) and 95.76 million people.

Conclusions: Epidemiological AD data are lacking in 41.5% of countries worldwide. The epidemiology of AD varies substantially with age and sex and is distributed unequally across geographical regions.

Publication types

  • Systematic Review

MeSH terms

  • Adult
  • Bayes Theorem
  • Child
  • Dermatitis, Atopic* / epidemiology
  • Female
  • Global Burden of Disease
  • Global Health
  • Humans
  • Incidence
  • Male
  • Prevalence